BIO
Bio-Rad Laboratories, Inc.
October 1, 2026 · market open
- Rarity
- 1.61
- Peak move
- −6.13%
- Float cap
- $6.8B
Bio-Rad Laboratories, Inc. is a multinational life science and clinical diagnostics company that develops, manufactures, and markets instruments, systems, reagents, and consumables. Its Life Science products serve universities, medical schools, pharmaceutical and biotechnology companies, government agencies, and food-testing laboratories, while its Clinical Diagnostics products support hospital, reference, transfusion, and physician office laboratories.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
2 events · 0 from SEC or newswire · 0 timed with the moveinstitutional_flowCalifornia State Teachers' Retirement System reported increasing its Bio-Rad Laboratories position by 27,700% in the second quarter, holding 6,097,105 shares after adding 6,075,173 shares.
analyst_ratingRBC Capital analyst Dan Leonard maintained an Outperform/Buy rating on Bio-Rad Laboratories with a $390 price target, the highest among covering analysts as of Sept 30, 2026.